These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23041022)

  • 21. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
    Kissling E; Valenciano M;
    Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
    Leval A; Hergens MP; Persson K; Örtqvist Å
    Euro Surveill; 2016 Oct; 21(43):. PubMed ID: 27813473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
    Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    Darvishian M; Dijkstra F; van Doorn E; Bijlsma MJ; Donker GA; de Lange MM; Cadenau LM; Hak E; Meijer A
    PLoS One; 2017; 12(1):e0169528. PubMed ID: 28068386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
    Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
    Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.
    Larrauri A; Savulescu C; Jiménez-Jorge S; Pérez-Breña P; Pozo F; Casas I; Ledesma J; de Mateo S;
    Gac Sanit; 2011; 25(1):23-8. PubMed ID: 21334788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.
    Pebody R; Hardelid P; Fleming D; McMenamin J; Andrews N; Robertson C; Thomas D; Sebastianpillai P; Ellis J; Carman W; Wreghitt T; Zambon M; Watson J
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis.
    Castilla J; Moran J; Martinez-Artola V; Reina G; Martinez-Baz I; Garcia Cenoz M; Alvarez N; Irisarri F; Arriazu M; Elia F; Salcedo E
    Euro Surveill; 2011 Feb; 16(7):. PubMed ID: 21345321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.
    Jimenez-Jorge S; Pozo F; de Mateo S; Delgado-Sanz C; Casas I; Garcia-Cenoz M; Castilla J; Sancho R; Etxebarriarteun-Aranzabal L; Quinones C; Martinez E; Vega T; Garcia A; Gimenez J; Vanrell JM; Castrillejo D; Larrauri A;
    Euro Surveill; 2014 Mar; 19(9):. PubMed ID: 24626206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.
    Remschmidt C; Rieck T; Bödeker B; Wichmann O
    BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.
    Castilla J; Martínez-Baz I; Navascués A; Fernandez-Alonso M; Reina G; Guevara M; Chamorro J; Ortega MT; Albéniz E; Pozo F; Ezpeleta C; ;
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.
    Skowronski D; Chambers C; Sabaiduc S; De Serres G; Dickinson J; Winter A; Fonseca K; Gubbay J; Charest H; Petric M; Krajden M; Mahmud S; Van Caeseele P; Kwindt T; Eshaghi A; Bastien N; Li Y
    Euro Surveill; 2014 Feb; 19(5):. PubMed ID: 24524234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.
    Ma C; Pan Y; Zhang L; Zhang Y; Wu S; Sun Y; Duan W; Zhang M; Wang Q; Yang P
    Hum Vaccin Immunother; 2017 Oct; 13(10):2379-2384. PubMed ID: 28846480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15.
    Domínguez A; Soldevila N; Toledo D; Godoy P; Espejo E; Fernandez MA; Mayoral JM; Castilla J; Egurrola M; Tamames S; Astray J; Morales-Suárez-Varela M;
    Euro Surveill; 2017 Aug; 22(34):. PubMed ID: 28857047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.